Collaborations, FDA Approvals, Appointments, Patents, and Stock Movements - Research Report on Aetna, United Therapeutics, Perrigo, Arena Pharmaceuticals, and Keryx Biopharmaceuticals
ownload free of charge at:
United Therapeutics Corporation Research Report
On December 20, 2013, United Therapeutics Corporation (United Therapeutics) announced that its Orenitram (treprostinil) Extended-Release Tablets have been approved by the United States Food and Drug Administration (FDA) for the treatment of pulmonary arterial hypertension (PAH) in WHO Group I patients to improve exercise capacity. Commenting on the approval, Roger Jeffs, Ph.D., President and Chief Operating Officer of United Therapeutics stated, "This approval marks the first time that the FDA has approved an orally administered prostacyclin analogue for any disease - and our fifth approval from the FDA for treatment of PAH - supporting our mission of providing a wider choice of PAH therapies for physicians and patients. We are grateful for the FDA's thorough review and will continue to build clinical support for the use of Orenitram." The Full Research Report on United Therapeutics Corporation - including full detailed breakdown, analyst ratings and price targets - is available to download free of charge at:
Perrigo Co. Research Report
On December 18, 2013, Perrigo Co. (Perrigo) announced that the Company has appointed Board of Directors, effective until its annual general meeting on November 2014. The Company informed that Joseph C. Papa, President and CEO of the Company, has been named Chairman of the Board, and Gary K. Kunkle, Jr., has been named Lead Independent Director. Perrigo added that Mr. Papa will head an 11-member Board that will include all of the former membePage: 1 2 3 4 5 Related biology technology :1
. New Drug Applications, FDA Approvals, Approved Acquisitions, Divestitures and Licensing Agreements - Research Report on Merck, Allergan, Mylan, AstraZeneca, and GlaxoSmithKline2
. California Biomedical Companies Report Higher Product Approvals, Fewer Delays3
. The 2013 CES: Patents, Legislation Reform, and the Growing Market for Patent Attorneys and Agents Reviewed by Wysebridge4
. Synthetic Biologics Announces Proposed Public Offering of Common Stock5
. MiMedx Group Announces Proposed Public Offering of Common Stock6
. Soligenix Announces Initial $600,000 Investment and up to $10.6 Million Common Stock Purchase Agreement with Lincoln Park Capital Fund, LLC7
. Northwest Biotherapeutics Announces Pricing Of Public Offering Of Common Stock And Warrants8
. Z Trim Holdings, Inc. Announces Pricing of Public Offering of Common Stock and Warrants9
. DURECT Announces Pricing of Public Offering of Common Stock10
. InterMune Announces Pricing of Public Offering of 6,500,000 Shares of Common Stock11
. Discovery Labs Prices $50 Million Public Offering of Common Stock
(Date:1/15/2014)... 2014 Bill Jacobs Automotive, a group of car dealerships headquartered ... the Heartland Blood Center and offering free oil change coupons ... place Saturday, Jan. 18 at the Bill Jacobs Cadillac and ... (Photo: http://photos.prnewswire.com/prnh/20140115/MN46637 ) The Bill Jacobs ...
(Date:1/15/2014)... (PRWEB) January 15, 2014 Cynvenio, a ... management through the genomic analysis of tumor cells in ... Finder™, a web-based cancer decision support application powered by ... with Cynvenio’s ClearID™ genomic test, Therapy Finder will provide ...
(Date:1/15/2014)... January 15, 2014 A study has been ... the Formula 1 track could help to tackle the problem ... (MAT), Stowhealth (a GP surgery based in Stowmarket) and academics ... Simplyhealth. Telemetry technology, which is inspired by equipment ...
(Date:1/15/2014)... DTS Language Services, Inc . is pleased ... Life Science organizations who need document translations. Clients will ... their documents in advance with a selection of nearly 50 ... often a critical factor in clinical and scientific fields, and ... Breaking Biology Technology:Join the Bill Jacobs Auto blood drive and receive a free oil change 2Cynvenio Offers New Breast Cancer Therapy Finder Application for its ClearID Breast Cancer Genomic Test 2Cynvenio Offers New Breast Cancer Therapy Finder Application for its ClearID Breast Cancer Genomic Test 3Formula 1 Technology Tackles Obesity in Unique Healthcare Partnership 2Formula 1 Technology Tackles Obesity in Unique Healthcare Partnership 3Formula 1 Technology Tackles Obesity in Unique Healthcare Partnership 4DTS Improves Efficiency for Life Science Document Translations 2
... Critical Path Immunology created to discover and develop ... for immune system-related diseases -, SAN FRANCISCO, March 31 ... with Beckman Coulter, Inc. to,establish a Center for Critical Path ... disease. This facility, which will be managed by,ITI and located ...
... (PHPG) today reported its consolidated, audited, financial,results for its ... in fiscal year 2007 were a record at $15,100,000 ... the year was our,highest ever at $17,802,000 as was ... 2006, respectively., Pre-tax income for the year was ...
... 31 BioMarin,Pharmaceutical Inc. (Nasdaq and SWX: BMRN) ... and distribution partner in Japan, has,received approval for ... Ministry of Health, Labour and Welfare,(MHLW) for the ... "We are proud to work with AnGes ...Cached Biology Technology:The Immune Tolerance Institute Announces Collaboration with Beckman Coulter Establishing a Multiplatform Immunophenotyping/Immunogenotyping Laboratory 2The Immune Tolerance Institute Announces Collaboration with Beckman Coulter Establishing a Multiplatform Immunophenotyping/Immunogenotyping Laboratory 3Photonic Products Group, Inc. Reports Record Financial Results for FY 2007 2Photonic Products Group, Inc. Reports Record Financial Results for FY 2007 3Photonic Products Group, Inc. Reports Record Financial Results for FY 2007 4Photonic Products Group, Inc. Reports Record Financial Results for FY 2007 5Photonic Products Group, Inc. Reports Record Financial Results for FY 2007 6Photonic Products Group, Inc. Reports Record Financial Results for FY 2007 7Photonic Products Group, Inc. Reports Record Financial Results for FY 2007 8Photonic Products Group, Inc. Reports Record Financial Results for FY 2007 9Naglazyme Approved by Japanese Ministry of Health 2Naglazyme Approved by Japanese Ministry of Health 3Naglazyme Approved by Japanese Ministry of Health 4
... BioGenex Super Sensitive Polymer-HRP ... a novel product based ... polymeric technology. This system ... to noise ratio and ...
... unit is an inexpensive personal or mini thermal ... process. Lightweight, with a small footprint, it can ... the researcher's desk. , The Gene Cycler thermal ... not have access to a large laboratory thermal ...
... Leu-CMK FLISP Assay with SR-101 ... Em=620 nm) • Accurately measure serine ... or permeabilization • B-Bridge's FLISP Kits ... serine proteases (FLISPs) to measure chymotrypsin-like ...
... He biolistic system enables 7-10 times more cells ... fits into the shocking chamber of the PDS-1000 ... wave over 7 microcarriers. By uniformly spreading the ... area, the system maximizes the number of cells ...Biology Products: